
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis
Itsuki Terao, Takahiro Tsuge, Kaori Endo, et al.
Journal of Affective Disorders (2023) Vol. 346, pp. 49-56
Closed Access | Times Cited: 14
Itsuki Terao, Takahiro Tsuge, Kaori Endo, et al.
Journal of Affective Disorders (2023) Vol. 346, pp. 49-56
Closed Access | Times Cited: 14
Showing 14 citing articles:
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials
Xue-jie Lou, Di Qiu, Zhuo-Yu Ren, et al.
Asian Journal of Psychiatry (2024) Vol. 95, pp. 103997-103997
Closed Access | Times Cited: 7
Xue-jie Lou, Di Qiu, Zhuo-Yu Ren, et al.
Asian Journal of Psychiatry (2024) Vol. 95, pp. 103997-103997
Closed Access | Times Cited: 7
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report
Charles R. Conway, Scott T. Aaronson, Harold A. Sackeïm, et al.
Brain stimulation (2024) Vol. 17, Iss. 2, pp. 448-459
Open Access | Times Cited: 5
Charles R. Conway, Scott T. Aaronson, Harold A. Sackeïm, et al.
Brain stimulation (2024) Vol. 17, Iss. 2, pp. 448-459
Open Access | Times Cited: 5
Treatment Options for Psychotic Depression in Adolescents: A Comprehensive Review
Violeta Pérez-Rodríguez, Clàudia Aymerich, Ana Catalán, et al.
Psychology Research and Behavior Management (2025) Vol. Volume 18, pp. 197-208
Open Access
Violeta Pérez-Rodríguez, Clàudia Aymerich, Ana Catalán, et al.
Psychology Research and Behavior Management (2025) Vol. Volume 18, pp. 197-208
Open Access
Innovative approaches in the treatment-resistant depression: exploring different therapeutic pathways
Anna Łysik, Katarzyna Logoń, Aleksandra Szczygieł, et al.
GeroScience (2025)
Open Access
Anna Łysik, Katarzyna Logoń, Aleksandra Szczygieł, et al.
GeroScience (2025)
Open Access
The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
Jiafang Wang, Yankun Feng, Qi Zhong, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Jiafang Wang, Yankun Feng, Qi Zhong, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model)
I. Yu. Dorozhenok, Alina Strukova
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 4, pp. 36-36
Closed Access
I. Yu. Dorozhenok, Alina Strukova
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 4, pp. 36-36
Closed Access
Leserbrief zu: Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt
Udo Bonnet
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 191-192
Closed Access
Udo Bonnet
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 191-192
Closed Access
Antwort zum Leserbrief: Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt
Florian Müller‐Dahlhaus, Michael Junginger, Wolfgang Kelsch
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 193-194
Closed Access
Florian Müller‐Dahlhaus, Michael Junginger, Wolfgang Kelsch
PSYCH up2date (2024) Vol. 18, Iss. 03, pp. 193-194
Closed Access
Esketamine Nasal Spray: Rapid Relief for TRD and Suicide Prevention—Mechanisms and Pharmacodynamics
Hui Song, Yang Luo, Lingzhi Fang
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2059-2071
Open Access
Hui Song, Yang Luo, Lingzhi Fang
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2059-2071
Open Access
Esketamine-Induced Dissociation: A Case Report
Jake Scarcella, Jeffrey S. MacDaniels, Lucinda Coffin, et al.
Journal of Psychoactive Drugs (2024), pp. 1-5
Closed Access
Jake Scarcella, Jeffrey S. MacDaniels, Lucinda Coffin, et al.
Journal of Psychoactive Drugs (2024), pp. 1-5
Closed Access
Augmentation mit Ketamin versus anderen Pharmaka – ein Vergleich
PSYCH up2date (2024) Vol. 18, Iss. 06, pp. 446-447
Closed Access
PSYCH up2date (2024) Vol. 18, Iss. 06, pp. 446-447
Closed Access
Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials
Itsuki Terao, Wakako Kodama
Psychiatry and Clinical Neurosciences Reports (2024) Vol. 3, Iss. 4
Closed Access
Itsuki Terao, Wakako Kodama
Psychiatry and Clinical Neurosciences Reports (2024) Vol. 3, Iss. 4
Closed Access